Whitehawk Therapeutics Inc (WHWK) Stock Analysis

What Whitehawk Therapeutics Inc does

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Key metrics

ETFs linked to WHWK

Broad-market and Healthcare sector ETFs an investor holding Whitehawk Therapeutics Inc is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how WHWK fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Whitehawk Therapeutics Inc?

Whitehawk Therapeutics Inc trades under the ticker WHWK on NASDAQ.

Which exchange is WHWK listed on?

WHWK is listed on NASDAQ.

What sector does Whitehawk Therapeutics Inc operate in?

Whitehawk Therapeutics Inc is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze WHWK in a portfolio?

PortView shows WHWK's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.